Icure Pharmaceutical Finalizes Director Candidates for EGM, No Shareholder Value Impact
Icure Pharmaceutical has corrected its previous disclosure regarding the temporary shareholder meeting scheduled for August 6, 2026, by finalizing the director candidates for election.
The candidates are inside directors Lee Jae-won and Jo A-in, and independent directors Hwang Cheol-min and Hong Seong-yong.
This correction is purely procedural, updating the status from undefined to confirmed, with no changes to capital structure or financials.
The company has not disclosed any additional capital raising or capital structure modification plans.
[AI Summary]This amended disclosure finalizes the director nominee slate for the upcoming EGM, representing a routine governance update with zero financial impact. While the new directors bring relevant experience, the disclosure does not trigger any immediate shareholder value event.
KOSDAQ Filing Information
[Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)